Site - Press Release Archive Press Release Archive 1998-2005 Keyword Search Year All2024202320222021202020192018201720162015201420132012201120102009200820072006 Apr 24 2024 Cytokinetics to Announce First Quarter Results on May 8, 2024 Apr 10 2024 Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress Apr 05 2024 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session Apr 02 2024 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 01 2024 Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference Mar 25 2024 Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session Mar 04 2024 Cytokinetics to Participate in March Investor Conferences Mar 01 2024 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Feb 29 2024 Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day Feb 28 2024 Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials Feb 27 2024 Cytokinetics Reports Fourth Quarter 2023 Financial Results Feb 13 2024 Cytokinetics to Announce Fourth Quarter Results on February 27, 2024 Feb 06 2024 Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference Jan 29 2024 Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program Jan 25 2024 Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten Jan 18 2024 Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024 Jan 03 2024 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jan 02 2024 Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference